D. E. Shaw & Co., Inc. Seelos Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.59 - $2.38 $182,419 - $273,055	-114,729 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.69 - $2.89 $35,777 - $61,181	21,170 Added 22.63%	114,729 $276,000
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $246,995 - $591,292	93,559 New	93,559 $247,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $117M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.